Spike-in SILAC proteomic approach reveals the vitronectin as an early molecular signature of liver fibrosis in hepatitis C infections with hepatic iron overload

Claudia Montaldo, Simone Mattei, Andrea Baiocchini, Nicolina Rotiroti, Franca Del Nonno, Leopoldo Paolo Pucillo, Angela Maria Cozzolino, Cecilia Battistelli, Laura Amicone, Giuseppe Ippolito, Vera van Noort, Alice Conigliaro, Tonino Alonzi, Marco Tripodi, Carmine Mancone

Research output: Contribution to journalArticle

Abstract

Hepatitis C virus (HCV)-induced iron overload has been shown to promote liver fibrosis, steatosis, and hepatocellular carcinoma. The zonal-restricted histological distribution of pathological iron deposits has hampered the attempt to perform large-scale in vivo molecular investigations on the comorbidity between iron and HCV. Diagnostic and prognostic markers are not yet available to assess iron overload-induced liver fibrogenesis and progression in HCV infections. Here, by means of Spike-in SILAC proteomic approach, we first unveiled a specific membrane protein expression signature of HCV cell cultures in the presence of iron overload. Computational analysis of proteomic dataset highlighted the hepatocytic vitronectin expression as the most promising specific biomarker for iron-associated fibrogenesis in HCV infections. Next, the robustness of our in vitro findings was challenged in human liver biopsies by immunohistochemistry and yielded two major results: (i) hepatocytic vitronectin expression is associated to liver fibrogenesis in HCV-infected patients with iron overload; (ii) hepatic vitronectin expression was found to discriminate also the transition between mild to moderate fibrosis in HCV-infected patients without iron overload.

Original languageEnglish
Pages (from-to)1107-1115
Number of pages9
JournalProteomics
Volume14
Issue number9
DOIs
Publication statusPublished - 2014

Fingerprint

Vitronectin
Iron Overload
Hepatitis C
Viruses
Hepacivirus
Liver Cirrhosis
Liver
Proteomics
Iron
Infection
Virus Diseases
Iron deposits
Biopsy
Biomarkers
Fatty Liver
Cell culture
Comorbidity
Hepatocellular Carcinoma
Membrane Proteins
Fibrosis

Keywords

  • Biomedicine
  • Hepatic iron overload
  • Hepatitis C infection
  • Liver fibrosis
  • Vitronectin

ASJC Scopus subject areas

  • Molecular Biology
  • Biochemistry
  • Medicine(all)

Cite this

Spike-in SILAC proteomic approach reveals the vitronectin as an early molecular signature of liver fibrosis in hepatitis C infections with hepatic iron overload. / Montaldo, Claudia; Mattei, Simone; Baiocchini, Andrea; Rotiroti, Nicolina; Nonno, Franca Del; Pucillo, Leopoldo Paolo; Cozzolino, Angela Maria; Battistelli, Cecilia; Amicone, Laura; Ippolito, Giuseppe; van Noort, Vera; Conigliaro, Alice; Alonzi, Tonino; Tripodi, Marco; Mancone, Carmine.

In: Proteomics, Vol. 14, No. 9, 2014, p. 1107-1115.

Research output: Contribution to journalArticle

Montaldo, Claudia ; Mattei, Simone ; Baiocchini, Andrea ; Rotiroti, Nicolina ; Nonno, Franca Del ; Pucillo, Leopoldo Paolo ; Cozzolino, Angela Maria ; Battistelli, Cecilia ; Amicone, Laura ; Ippolito, Giuseppe ; van Noort, Vera ; Conigliaro, Alice ; Alonzi, Tonino ; Tripodi, Marco ; Mancone, Carmine. / Spike-in SILAC proteomic approach reveals the vitronectin as an early molecular signature of liver fibrosis in hepatitis C infections with hepatic iron overload. In: Proteomics. 2014 ; Vol. 14, No. 9. pp. 1107-1115.
@article{e4afdee1805e43298cce6acc2b9c2b82,
title = "Spike-in SILAC proteomic approach reveals the vitronectin as an early molecular signature of liver fibrosis in hepatitis C infections with hepatic iron overload",
abstract = "Hepatitis C virus (HCV)-induced iron overload has been shown to promote liver fibrosis, steatosis, and hepatocellular carcinoma. The zonal-restricted histological distribution of pathological iron deposits has hampered the attempt to perform large-scale in vivo molecular investigations on the comorbidity between iron and HCV. Diagnostic and prognostic markers are not yet available to assess iron overload-induced liver fibrogenesis and progression in HCV infections. Here, by means of Spike-in SILAC proteomic approach, we first unveiled a specific membrane protein expression signature of HCV cell cultures in the presence of iron overload. Computational analysis of proteomic dataset highlighted the hepatocytic vitronectin expression as the most promising specific biomarker for iron-associated fibrogenesis in HCV infections. Next, the robustness of our in vitro findings was challenged in human liver biopsies by immunohistochemistry and yielded two major results: (i) hepatocytic vitronectin expression is associated to liver fibrogenesis in HCV-infected patients with iron overload; (ii) hepatic vitronectin expression was found to discriminate also the transition between mild to moderate fibrosis in HCV-infected patients without iron overload.",
keywords = "Biomedicine, Hepatic iron overload, Hepatitis C infection, Liver fibrosis, Vitronectin",
author = "Claudia Montaldo and Simone Mattei and Andrea Baiocchini and Nicolina Rotiroti and Nonno, {Franca Del} and Pucillo, {Leopoldo Paolo} and Cozzolino, {Angela Maria} and Cecilia Battistelli and Laura Amicone and Giuseppe Ippolito and {van Noort}, Vera and Alice Conigliaro and Tonino Alonzi and Marco Tripodi and Carmine Mancone",
year = "2014",
doi = "10.1002/pmic.201300422",
language = "English",
volume = "14",
pages = "1107--1115",
journal = "Proteomics",
issn = "1615-9853",
publisher = "Wiley-VCH Verlag",
number = "9",

}

TY - JOUR

T1 - Spike-in SILAC proteomic approach reveals the vitronectin as an early molecular signature of liver fibrosis in hepatitis C infections with hepatic iron overload

AU - Montaldo, Claudia

AU - Mattei, Simone

AU - Baiocchini, Andrea

AU - Rotiroti, Nicolina

AU - Nonno, Franca Del

AU - Pucillo, Leopoldo Paolo

AU - Cozzolino, Angela Maria

AU - Battistelli, Cecilia

AU - Amicone, Laura

AU - Ippolito, Giuseppe

AU - van Noort, Vera

AU - Conigliaro, Alice

AU - Alonzi, Tonino

AU - Tripodi, Marco

AU - Mancone, Carmine

PY - 2014

Y1 - 2014

N2 - Hepatitis C virus (HCV)-induced iron overload has been shown to promote liver fibrosis, steatosis, and hepatocellular carcinoma. The zonal-restricted histological distribution of pathological iron deposits has hampered the attempt to perform large-scale in vivo molecular investigations on the comorbidity between iron and HCV. Diagnostic and prognostic markers are not yet available to assess iron overload-induced liver fibrogenesis and progression in HCV infections. Here, by means of Spike-in SILAC proteomic approach, we first unveiled a specific membrane protein expression signature of HCV cell cultures in the presence of iron overload. Computational analysis of proteomic dataset highlighted the hepatocytic vitronectin expression as the most promising specific biomarker for iron-associated fibrogenesis in HCV infections. Next, the robustness of our in vitro findings was challenged in human liver biopsies by immunohistochemistry and yielded two major results: (i) hepatocytic vitronectin expression is associated to liver fibrogenesis in HCV-infected patients with iron overload; (ii) hepatic vitronectin expression was found to discriminate also the transition between mild to moderate fibrosis in HCV-infected patients without iron overload.

AB - Hepatitis C virus (HCV)-induced iron overload has been shown to promote liver fibrosis, steatosis, and hepatocellular carcinoma. The zonal-restricted histological distribution of pathological iron deposits has hampered the attempt to perform large-scale in vivo molecular investigations on the comorbidity between iron and HCV. Diagnostic and prognostic markers are not yet available to assess iron overload-induced liver fibrogenesis and progression in HCV infections. Here, by means of Spike-in SILAC proteomic approach, we first unveiled a specific membrane protein expression signature of HCV cell cultures in the presence of iron overload. Computational analysis of proteomic dataset highlighted the hepatocytic vitronectin expression as the most promising specific biomarker for iron-associated fibrogenesis in HCV infections. Next, the robustness of our in vitro findings was challenged in human liver biopsies by immunohistochemistry and yielded two major results: (i) hepatocytic vitronectin expression is associated to liver fibrogenesis in HCV-infected patients with iron overload; (ii) hepatic vitronectin expression was found to discriminate also the transition between mild to moderate fibrosis in HCV-infected patients without iron overload.

KW - Biomedicine

KW - Hepatic iron overload

KW - Hepatitis C infection

KW - Liver fibrosis

KW - Vitronectin

UR - http://www.scopus.com/inward/record.url?scp=84898630514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898630514&partnerID=8YFLogxK

U2 - 10.1002/pmic.201300422

DO - 10.1002/pmic.201300422

M3 - Article

C2 - 24616218

AN - SCOPUS:84898630514

VL - 14

SP - 1107

EP - 1115

JO - Proteomics

JF - Proteomics

SN - 1615-9853

IS - 9

ER -